Literature DB >> 25658371

Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Chen Yu1, Yanxia Liu2, Tianhua Ma1, Kai Liu1, Shaohua Xu1, Yu Zhang1, Honglei Liu3, Marie La Russa4, Min Xie1, Sheng Ding5, Lei S Qi6.   

Abstract

The bacterial CRISPR-Cas9 system has emerged as an effective tool for sequence-specific gene knockout through non-homologous end joining (NHEJ), but it remains inefficient for precise editing of genome sequences. Here we develop a reporter-based screening approach for high-throughput identification of chemical compounds that can modulate precise genome editing through homology-directed repair (HDR). Using our screening method, we have identified small molecules that can enhance CRISPR-mediated HDR efficiency, 3-fold for large fragment insertions and 9-fold for point mutations. Interestingly, we have also observed that a small molecule that inhibits HDR can enhance frame shift insertion and deletion (indel) mutations mediated by NHEJ. The identified small molecules function robustly in diverse cell types with minimal toxicity. The use of small molecules provides a simple and effective strategy to enhance precise genome engineering applications and facilitates the study of DNA repair mechanisms in mammalian cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25658371      PMCID: PMC4461869          DOI: 10.1016/j.stem.2015.01.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  32 in total

1.  Action of brefeldin A blocked by activation of a pertussis-toxin-sensitive G protein.

Authors:  N T Ktistakis; M E Linder; M G Roth
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

3.  Studies of adenovirus type 3 infection treated with methisazone and trifluorothymidine.

Authors:  J M Little; D W Lorenzetti; D C Brown; H H Schweem; B R Jones; H E Kaufman
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

4.  Assignment of the vascular smooth muscle actin gene ACTSA to human chromosome 10.

Authors:  H Ueyama; G Bruns; N Kanda
Journal:  Jinrui Idengaku Zasshi       Date:  1990-06

5.  Knockout rats via embryo microinjection of zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Yevgeniy Freyvert; Bryan Zeitler; Jeffrey C Miller; Vivian M Choi; Shirin S Jenkins; Adam Wood; Xiaoxia Cui; Xiangdong Meng; Anna Vincent; Stephen Lam; Mieczyslaw Michalkiewicz; Rebecca Schilling; Jamie Foeckler; Shawn Kalloway; Hartmut Weiler; Séverine Ménoret; Ignacio Anegon; Gregory D Davis; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Howard J Jacob; Roland Buelow
Journal:  Science       Date:  2009-07-24       Impact factor: 47.728

6.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

Authors:  H Mitsuya; K J Weinhold; P A Furman; M H St Clair; S N Lehrman; R C Gallo; D Bolognesi; D W Barry; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.

Authors:  E R Parmee; H O Ok; M R Candelore; L Tota; L Deng; C D Strader; M J Wyvratt; M H Fisher; A E Weber
Journal:  Bioorg Med Chem Lett       Date:  1998-05-05       Impact factor: 2.823

8.  2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK).

Authors:  Jonathan J Hollick; Bernard T Golding; Ian R Hardcastle; Niall Martin; Caroline Richardson; Laurent J M Rigoreau; Graeme C M Smith; Roger J Griffin
Journal:  Bioorg Med Chem Lett       Date:  2003-09-15       Impact factor: 2.823

9.  A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; A C Bowling; D Patterson; T B Usdin; P Sapp; E Mezey; D McKenna-Yasek; J O'Regan; Z Rahmani; R J Ferrante
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

10.  Self versus non-self discrimination during CRISPR RNA-directed immunity.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Nature       Date:  2010-01-13       Impact factor: 49.962

View more
  168 in total

Review 1.  Salient Features of Endonuclease Platforms for Therapeutic Genome Editing.

Authors:  Michael T Certo; Richard A Morgan
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

Review 2.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

3.  Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.

Authors:  Xiangjin Kang; Wenyin He; Yuling Huang; Qian Yu; Yaoyong Chen; Xingcheng Gao; Xiaofang Sun; Yong Fan
Journal:  J Assist Reprod Genet       Date:  2016-04-06       Impact factor: 3.412

Review 4.  Applications of chemogenomic library screening in drug discovery.

Authors:  Lyn H Jones; Mark E Bunnage
Journal:  Nat Rev Drug Discov       Date:  2017-01-20       Impact factor: 84.694

5.  Precise and efficient scarless genome editing in stem cells using CORRECT.

Authors:  Dylan Kwart; Dominik Paquet; Shaun Teo; Marc Tessier-Lavigne
Journal:  Nat Protoc       Date:  2017-01-19       Impact factor: 13.491

Review 6.  Control of gene editing by manipulation of DNA repair mechanisms.

Authors:  Eric Danner; Sanum Bashir; Saniye Yumlu; Wolfgang Wurst; Benedikt Wefers; Ralf Kühn
Journal:  Mamm Genome       Date:  2017-04-03       Impact factor: 2.957

Review 7.  Ways of improving precise knock-in by genome-editing technologies.

Authors:  Svetlana A Smirnikhina; Arina A Anuchina; Alexander V Lavrov
Journal:  Hum Genet       Date:  2018-11-02       Impact factor: 4.132

8.  CRISPR-based engineering of gene knockout cells by homology-directed insertion in polyploid Drosophila S2R+ cells.

Authors:  Baolong Xia; Gabriel Amador; Raghuvir Viswanatha; Jonathan Zirin; Stephanie E Mohr; Norbert Perrimon
Journal:  Nat Protoc       Date:  2020-09-21       Impact factor: 13.491

9.  Abundance and localization of human UBE3A protein isoforms.

Authors:  Carissa L Sirois; Judy E Bloom; James J Fink; Dea Gorka; Steffen Keller; Noelle D Germain; Eric S Levine; Stormy J Chamberlain
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

10.  CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations.

Authors:  Alexis Guernet; Sathish Kumar Mungamuri; Dorthe Cartier; Ravi Sachidanandam; Anitha Jayaprakash; Sahil Adriouch; Myriam Vezain; Françoise Charbonnier; Guy Rohkin; Sophie Coutant; Shen Yao; Hassan Ainani; David Alexandre; Isabelle Tournier; Olivier Boyer; Stuart A Aaronson; Youssef Anouar; Luca Grumolato
Journal:  Mol Cell       Date:  2016-07-21       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.